Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Timmer, Antje"'
Autor:
Timmer, Antje1 antje.timmer@klinik.uni-regensburg.de, Hilsden, Robert J.2 rhilsden@acs.ucalgary.ca, Sutherland, Lloyd R.1 lsutherl@acs.ucalgary.ca, Timmer, A1 (AUTHOR), Hilsden, R J (AUTHOR), Sutherland, L R (AUTHOR)
Publikováno v:
BMC Medical Research Methodology. 2001, Vol. 1, p13-13. 1p. 5 Charts.
Autor:
Fortuny J; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., von Gersdorff G; Department of Internal Medicine-QiN-group, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Lassalle R; Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, Bordeaux, France., Linder M; Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden., Overbeek J; Department Research, PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Reinold J; Clinical Epidemiology Group, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Toft G; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark., Timmer A; Epidemiology and Biometry Group, Carl von Ossietzky University Oldenburg, Oldenburg, Germany., Dress J; Research Data Center (DaTraV), Federal Institute for Drugs and Medical Devices-BfArM, Bonn, Germany., Blin P; Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, Bordeaux, France., Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, Bordeaux, France., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark., Franzoni C; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Herings R; Department Research, PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Epidemiology and Biostatistics, Amsterdam, The Netherlands., Kollhorst B; Clinical Epidemiology Group, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Moore N; Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, Bordeaux, France., Odsbu I; Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden., Perez-Gutthann S; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Schink T; Clinical Epidemiology Group, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Rascher K; Department of Internal Medicine-QiN-group, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Rasouliyan L; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Rothman KJ; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Waltham, Massachusetts, USA., Saigi-Morgui N; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Schaller M; Department of Internal Medicine-QiN-group, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Smits E; Department Research, PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Forstner M; Mesama Consulting, Solothurn, Switzerland., Bénichou J; Department of Biostatistics, Rouen University Hospital and Inserm U 1018, University of Rouen, Rouen, France., Bircher AJ; Allergy Unit, Dermatology Clinic University Hospital Basel, Basel, Switzerland.; Faculty of Biomedicine, Università della Svizzera italiana, Lugano, Switzerland., Garbe E; Clinical Epidemiology Group, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Rampton DS; Department of Gastroenterology, Royal London Hospital, London, UK., Gutierrez L; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Oct; Vol. 30 (10), pp. 1447-1457. Date of Electronic Publication: 2021 Jul 12.
Autor:
Pladevall-Vila M; Epidemiology, RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain. mpladevall@rti.org.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA. mpladevall@rti.org., Pottegård A; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark., Schink T; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Reutfors J; Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Morros R; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.; Institut Català de la Salut, Barcelona, Spain.; Plataforma SCReN, UICEC IDIAP Jordi Gol, Barcelona, Spain., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragon, REDISSEC ISCIII, Miguel Servet University Hospital, Zaragoza, Spain., Timmer A; Division of Epidemiology and Biometry, Medical Faculty, Carl von Ossietzky University, Oldenburg, Germany., Forns J; Epidemiology, RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain., Hellfritzsch M; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark., Reinders T; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Hägg D; Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Giner-Soriano M; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.; Institut Català de la Salut, Barcelona, Spain., Prados-Torres A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragon, REDISSEC ISCIII, Miguel Servet University Hospital, Zaragoza, Spain., Cainzos-Achirica M; Epidemiology, RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain., Hallas J; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark., Brandt L; Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Cortés J; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAPJGol), Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.; Institut Català de la Salut, Barcelona, Spain.; Universitat Politècnica de Catalunya, Departament d'Estadística i Investigació Operativa, Barcelona, Spain., Aguado J; Epidemiology, RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain., Perlemuter G; AP-HP, Hôpital Antoine Béclère, Service d'Hépato-gastroentérologie, 92140, Clamart, France.; Univ Paris-Sud/Paris-Saclay, Faculté de Médecine, Paris-Sud, 94270, Kremlin-Bicêtre, France.; INSERM U996, Clamart, 92140, France., Falissard B; CESP INSERM U1018, Université Paris-Saclay, Université Paris-Sud, UVSQ, APHP, Paris, France., Castellsagué J; Epidemiology, RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain., Jacquot E; Pharmacoepidemiology Department, Servier, Suresnes, France., Deltour N; Pharmacoepidemiology Department, Servier, Suresnes, France., Perez-Gutthann S; Epidemiology, RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain.
Publikováno v:
CNS drugs [CNS Drugs] 2019 Apr; Vol. 33 (4), pp. 383-395.